Alterity Therapeutics Ltd.ASX: ATH

Results of Meeting

· Issued by Alterity Therapeutics Ltd. via ASX

Filed with ASX · · 4 pages · English

Summary by 6ix AI

The resolutions included the adoption of the remuneration report and the re-election of directors, among others, with all resolutions carried successfully. The document also provides insights into the company's focus on developing therapies for neurodegenerative diseases, particularly Multiple System Atrophy.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Results of 2026 Annual General Meeting MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA - 20 November 2026: In accordance with ASX Listing Rule 3.13.2 and Section 251AA of the Corporations Act 2001 (Cth), the attached information is provided in relation to the resolutions passed by the shareholders of...

Alterity Therapeutics Ltd. on 6ix

Earlier from Alterity Therapeutics

All Alterity Therapeutics news releases